MediciNova

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MediciNova and other ETFs, options, and stocks.

About MNOV

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. 

CEO
Yuichi Iwaki
CEOYuichi Iwaki
Employees
13
Employees13
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2000
Founded2000
Employees
13
Employees13

MNOV Key Statistics

Market cap
63.15M
Market cap63.15M
Price-Earnings ratio
-5.23
Price-Earnings ratio-5.23
Dividend yield
Dividend yield
Average volume
70.75K
Average volume70.75K
High today
High today
Low today
Low today
Open price
$1.30
Open price$1.30
Volume
0.00
Volume0.00
52 Week high
$2.20
52 Week high$2.20
52 Week low
$1.13
52 Week low$1.13

Stock Snapshot

With a market cap of 63.15M, MediciNova(MNOV) trades at $1.28. The stock has a price-to-earnings ratio of -5.23.

On 2025-12-26, MediciNova(MNOV) stock opened at $1.30, reached a high of —, and a low of —.

The MediciNova(MNOV)'s current trading volume is 0, compared to an average daily volume of 70.75K.

During the past year, MediciNova(MNOV) stock moved between $1.13 at its lowest and $2.20 at its peak.

During the past year, MediciNova(MNOV) stock moved between $1.13 at its lowest and $2.20 at its peak.

People also own

Based on the portfolios of people who own MNOV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.